who we are
Your Pharmaceutical Essentials Partner
Dr Ashleys Limited is a Hong Kong & EU based pharmaceutical trailblazer & a global leader in the development and manufacturing of specialist and complex active pharmaceutical ingredients (APIs) for pharma and biotech companies. Dr Ashleys Limited’s capabilities span a wide range of development technologies and specialties—all backed by comprehensive industry knowledge and experience. Whether you need a partner in development or an experienced leader to navigate complex scale-up, Dr Ashleys is the final destination. Our deep knowledge of APIs manufacturing and processes is supported by a collaborative, consultative approach to ensure your expectations and milestones are met. Extensive portfolio of generic APIs. Our products cover a wide range of therapeutic classes, such as anti-cancer, anti-malarial, and pain management. Our APIs offering is supported by our network of GMP-compliant commercial manufacturing facilities in Europe and North America, to meet your global product requirements.
Dr Ashleys Limited has made strategic partnership with leading manufacturing units worldwide to cater to the growing demands of the companies. We have a presence of more than 60 countries with a dedicated R & D facility at Riga in Latvia.
Dr Ashleys Limited was born in the year 2012 as a pharmaceutical company to deliver world-class products. Over the years, Dr Ashleys has witnessed Exponential growth in meeting with clients complex demands of delivering world-class products as a reliable & trusted partner. Our vision is to be the world’s most trusted, reliable and innovative drug development and delivery partner by upholding the highest industry standards and exceeding customer expectations, while driving strong, sustained growth for the company. Our corporate responsibility (CR) strategy and commitments represent how we put our values into action to run our business and achieve our mission to help people live better, healthier lives.
With a commitment to delivering the best services, we have emerged as the market leader in pharmaceutical contract manufacturing and trading in Hong Kong, and we have also made our presence felt on the international stage.
A Diverse Product Portfolio
Our extensive product portfolio comprises over 85 specialized pharmaceutical offerings, ranging from Tablets, Capsules, Liquid, Dry Syrups, to Ointments, encompassing both Beta and non-beta sections.
Our success story is a testament to the expertise of our highly competent team. Our professionals, well-versed in pharmaceutics, ensure the timely execution of projects with a competitive edge. We take pride in providing 100% Excise and Sales Tax benefits to our valued customers.
Quality is paramount at Dr. Ashleys Limited. We ensure that our partners hold the necessary food or drug licenses and adhere to FDA GMP-WHO and ISO certifications. This unwavering commitment to quality makes us a reliable and trustworthy source for a wide range of pharmaceutical ingredients, catering to the diverse needs of the pharmaceutical industry.
At Dr. Ashleys Limited, we continue to evolve, innovate, and expand our reach to meet the ever-changing demands of the pharmaceutical and nutraceutical landscape. We are dedicated to being your preferred partner in sourcing essential pharmaceutical solutions, ensuring access to high-quality products that contribute to a healthier world.
Our major Products
An Impactful Merger
Financial Milestone for Dr Ashleys Limited
Technological Advancements at Dr Ashleys Limited
Research and Development Investment at Dr Ashleys Limited
International Export Success for Dr Ashleys Limited
Market Expansion for Dr Ashleys Limited
GMP Certification for Dr Ashleys Limited:
First Contract Manufacturing Deal
Incorporation of Dr Ashleys Limited in Hong Kong